Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This is a A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial to
Evaluate the Efficacy and Safety of Different Doses of OPS-2071 in the Treatment of Irritable
Bowel Syndrome of Diarrhea type (IBS-D).The trial is mainly divided into three periods:
screening period, treatment period and follow-up period.